India’s insurance sector is approaching a strategic inflection point

For years, India’s insurance industry has been evaluated through familiar measures: premium growth, market share, distribution reach, and solvency margins. That framework is about to change. Three reforms, 100% FDI, Ind AS 117, and a forthcoming Risk-Based Capital (RBC) framework, landing in close succession are about to do something India’s insurance industry has never experienced: make every product’s economics visible, every insurer’s capital position explicit, and every investor’s evaluation framework global. Each is significant on its own. Together, they represent the most important structural reset the sector has experienced in nearly two decades.

FDI change is often framed as a capital story. It is more precisely a benchmarking story. When global investors hold full ownership positions, they no longer evaluate performance only through the lens of Indian GAAP. They look at CSM quality, new business margin, and capital efficiency. Gross written premium and GAAP profit give way to CSM stock and capital generation as the measures that matter. Indian insurers need to build fluency in these metrics from the start of transition, not as an afterthought once foreign capital has already formed its first impression.

Ind AS 117 extends beyond disclosure norms. Indian insurers will start reporting liabilities based on globally comparable principles built on current estimates of future cash flows, explicit risk adjustment and market-linked discount rates. Under IGAAP, long-duration savings products, guaranteed-return plans, bundled group policies could generate sizable premium volumes while obscuring thin underlying economics. Ind AS 117 ends this arrangement. Every group of contracts must carry its own Contractual Service Margin (CSM), recognised only as the insurer delivers service. Products can no longer cross-subsidise each other. Each group of contracts stands on its own economics.

The proposed RBC framework is the second stage of this transformation, and in many ways the harder one. Unlike the current factor-based regime, RBC aligns required capital with the actual risk in each insurer’s book. Products with long-duration guaranteed liabilities become capital-intensive; protection and unit-linked products do not. When both frameworks operate simultaneously, the pressure on savings-heavy portfolios is not additive, it is compounding.

The numbers from markets that went first are already in the public domain, and worth reading carefully. In South Korea, Samsung Life reported 2023 net profit up 19.7% and CSM of KRW 12.2 trillion. But beneath them, required capital for savings-heavy books rose two to three times, several insurers fell below the 100% regulatory minimum before transitional relief was applied, and regulator was ultimately forced to cut the solvency threshold from 150% to 130–140%. The response was a deliberate pivot toward health products, targeting 85% health CSM share within two years.

Hong Kong and the UK tell the investor expectations side of the same story. AIA’s VONB grew 37% to over $2 billion in the first half of 2023. Legal & General’s CSM “store of future profit” grew from £13.8 billion to £14.8 billion in 18 months, replacing embedded value as the primary investor KPI almost immediately after transition. Prudential’s 2023 new-business profit rose 45% to $3.1 billion; within a single year the growth narrative had shifted from premiums to new-business CSM. This is the narrative India’s insurers will need to construct. Future profitability becomes more transparent, more comparable, more directly linked to product economics. That is not a small adjustment; it is a fundamental change in how the industry will be valued.

The product level implications follow directly. India’s traditional endowment savings, a significant share of the current life mix are doubly exposed under both frameworks simultaneously. ULIPs, where investment risk passes to the policyholder, are among the most capital-efficient products under RBC; pure protection generates fast, high-quality CSM. However, guaranteed savings products will not disappear as it is evident that no major market has eliminated them, but capital, innovation and management attention will migrate toward designs that combine profitability with capital efficiency.

What makes this moment particularly significant is the context it sits within. India’s ambition of “Insurance for All by 2047” means the country needs to reach gig workers, informal-sector earners, rural households, and first-time buyers in Tier II and III cities—segments of Indian populations that traditional product design never served economically. As insurers move focus from low-margin products that cannot sustain CSM economics, protection, health, and micro-insurance become commercially compelling on their own merits—clean CSM, capital-light under RBC, and precisely what the government is trying to scale. IRDAI’s Bima Trinity: Bima Sugam, Bima Vistar, and Bima Vahaks, provides the distribution infrastructure. Overall, the accounting reform and inclusion agenda point at the same market.

Finance and actuarial teams are already deployed on Ind AS 117 implementations. What separates insurers who will lead from those who will lag is whether leadership treats this as strategic reset or accounting migration. Those who move well will audit their portfolios honestly, exit products that cannot earn margins, pivot toward protection and inclusion business with durable CSM, and build an investor narrative anchored in future profitability rather than volume. Indian insurers carry an advantage that India’s peers did not have—a clear sight line of what is coming before it arrives. The question is whether that foreknowledge translates into action. How it does will define the competitive landscape for the next decade.

(Malani is India Leader, Insurance Practice, BCG; Sharma is Project Leader, BCG. Views are personal.)